1,227 results on '"Lee, Phil Hyu"'
Search Results
2. A human brain atlas of chi-separation for normative iron and myelin distributions
3. Differential effects of cholesterol levels on cognition according to body mass index in Parkinson’s disease
4. Different effect of hypo- and hypermetabolism on cognition in dementia with Lewy bodies: are they coupled or independent?
5. Hypoperfusion in Alzheimer’s Disease–Prone Regions and Dementia Conversion in Parkinson’s Disease
6. Patterns of regional cerebral hypoperfusion in early Parkinson's disease: Clinical implications
7. An interpretable multiparametric radiomics model of basal ganglia to predict dementia conversion in Parkinson’s disease
8. Patterns of striatal dopamine depletion and motor deficits in de novo Parkinson’s disease
9. Regional Burden of Enlarged Perivascular Spaces and Cognition and Neuropsychiatric Symptoms in Drug-Naive Patients With Parkinson Disease
10. Opicapone to Treat Early Wearing‐off in Parkinson's Disease Patients: The Korean ADOPTION Trial
11. Evaluating the validity and reliability of the Korean version of Scales for Outcomes in Parkinson’s Disease–Cognition
12. White matter connectivity networks predict levodopa-induced dyskinesia in Parkinson’s disease
13. Sandwich spatial saturation for neuromelanin-sensitive MRI: Development and multi-center trial
14. Identifying the white matter structural network of motor reserve in early Parkinson's disease
15. Does dopamine deficiency affect sex-dependent prognosis in Parkinson's disease?
16. Associations between white matter hyperintensities, striatal dopamine loss, and cognition in drug-naïve Parkinson's disease
17. Author Correction: Mapping brain structural differences and neuroreceptor correlates in Parkinson’s disease visual hallucinations
18. Priming mesenchymal stem cells with α-synuclein enhances neuroprotective properties through induction of autophagy in Parkinsonian models
19. Contracted thalamic shape is associated with early development of levodopa-induced dyskinesia in Parkinson’s disease
20. Effects of Alzheimer’s genetic risk scores and CSF biomarkers in de novo Parkinson’s Disease
21. Implication of EEG theta/alpha and theta/beta ratio in Alzheimer’s and Lewy body disease
22. Mapping brain structural differences and neuroreceptor correlates in Parkinson’s disease visual hallucinations
23. Local striatal volume and motor reserve in drug-naïve Parkinson’s disease
24. Baseline cognitive profile is closely associated with long-term motor prognosis in newly diagnosed Parkinson’s disease
25. Comparing MoCA Performance in Parkinson’s disease: Age and Education-Adjusted Cutoffs vs. Machine Learning
26. Apolipoprotein E4, amyloid, and cognition in Alzheimer's and Lewy body disease
27. Effects of baseline serum uric acid and apolipoprotein E4 on longitudinal cognition and cerebral metabolism
28. Different patterns of β-amyloid deposition in patients with Alzheimer's disease according to the presence of mild parkinsonism
29. Gut microbiota-derived metabolite trimethylamine N-oxide as a biomarker in early Parkinson's disease
30. The pattern of FP-CIT PET in pure white matter hyperintensities–related vascular parkinsonism
31. Initial motor reserve and long-term prognosis in Parkinson's disease
32. Mesenchymal stem cells modulate misfolded α-synuclein in parkinsonian disorders: A multitarget disease-modifying strategy
33. Gender-specific effect of urate on white matter integrity in Parkinson's disease
34. Patterns of olfactory functional networks in Parkinson's disease dementia and Alzheimer's dementia
35. Impaired functional connectivity of sensorimotor network predicts recovery in drug-induced parkinsonism
36. Distinguishing between dementia with Lewy bodies and Alzheimer's disease using metabolic patterns
37. Association of β-Amyloid and Basal Forebrain With Cortical Thickness and Cognition in Alzheimer and Lewy Body Disease Spectra
38. Functional Brain Networks of Minor and Well‐Structured Major Hallucinations in Parkinson's Disease
39. Effects of dihydropyridines on the motor and cognitive outcomes of patients with Parkinson's disease
40. Association of Sleep Disturbances With Brain Amyloid and Tau Burden, Cortical Atrophy, and Cognitive Dysfunction Across the AD Continuum
41. Hippocampal Perfusion Affects Motor and Cognitive Functions in Parkinson's Disease: An Early‐Phase 18F‐FP‐CIT PET Study
42. Donepezil for mild cognitive impairment in Parkinson’s disease
43. Implication of metabolic and dopamine transporter PET in dementia with Lewy bodies
44. White matter hyperintensities as a predictor of freezing of gait in Parkinson's disease
45. Midbrain atrophy in patients with presymptomatic progressive supranuclear palsy-Richardson's syndrome
46. Detrimental effect of type 2 diabetes mellitus in a large case series of Parkinson's disease
47. Mild cognitive impairment reverters have a favorable cognitive prognosis and cortical integrity in Parkinson's disease
48. Amyloid-β-related and unrelated cortical thinning in dementia with Lewy bodies
49. Olfactory dysfunction in Alzheimer's disease– and Lewy body–related cognitive impairment
50. Functional Brain Networks of Minor and Well‐Structured Major Hallucinations in Parkinson's Disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.